Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284739 · ClinicalTrials.gov registry record · Phase 2
Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00284739 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 20 participants.
The verdict
NCT00284739, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Intracavitary injection of low dose alteplase into loculated abdominopelvic abscesses will reduce the duration of percutaneous drainage and increase the proportion of successful drainages.
Interventions
- OTHER saline
- DRUG Alteplase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00284739
The ClinicalTrials.gov registry entry for NCT00284739 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT00284739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00284739 about?
NCT00284739 is a clinical study titled "Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses". Intracavitary injection of low dose alteplase into loculated abdominopelvic abscesses will reduce the duration of percutaneous drainage and increase the proportion of successful drainages.
What is the current status of trial NCT00284739?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2006-02. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00284739?
The interventions under investigation include: saline (OTHER), Alteplase (DRUG).
Who is sponsoring clinical trial NCT00284739?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.